CpG oligodeoxynucleotides protect mice from lethal challenge with Candida albicans via a pathway involving tumor necrosis factor-α-dependent interleukin-12 induction

FEMS Immunology and Medical Microbiology

Volumn 51, Issue 1, 2007, Pages 155-162

  Choi, Jung Hwa ^a   Ko, Hyun Mi ^a   Park, Sung Jun ^a   Kim, Kyoung Jin ^a   Kim, So Hee ^a   Im, Suhn Young ^a  

^a Chonnam National University   (South Korea)

Author keywords

Candida albicans; CpG ODN; IL 12; TNF

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; PYRROLIDINE DITHIOCARBAMATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ACTIVITY; FEMALE; FUNGUS GROWTH; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL;

ANIMALS; CANDIDIASIS; FEMALE; INTERFERON TYPE II; INTERLEUKIN-12; KIDNEY; MICE; MICE, INBRED C57BL; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548579189     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2007.00292.x     Document Type: Article

References (44)

1. Carson DA Raz E (1997) Oligonucleotide adjuvants for T helper 1 (Th1)-specific vaccination. J Exp Med 186 : 1621 1622.
2. Choi JH, Chung WJ, Han SJ et al 2000) Selective involvement of reactive oxygen intermediates in platelet-activating factor-mediated activation of NF-kappaB. Inflammation 24 : 385 398.
3. Choi JH, Ko HM, Kim JW, Lee HK, Han SS, Chun SB Im SY (2001) Platelet-activating factor-induced early activation of NF-kappa B plays a crucial role for organ clearance of Candida albicans. J Immunol 166 : 5139 5144.
4. Chu RS, Targoni OS, Krieg AM, Lehmann PV Harding CV (1997) CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 186 : 1623 1631.
5. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M Trinchieri G (1993) Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178 : 1041 1048.
6. Djeu JY, Blanchard DK, Halkias D Friedman H (1986) Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-γ and tumor necrosis factor. J Immunol 137 : 2980 2984.
7. Elkins KL, Rhinehart-Jones TR, Culkin SJ, Yee D Winegar RK (1996) Minimal requirements for murine resistance to infection with Francisella tularensis LVS. Infect Immun 64 : 3288 3293.
8. Fang H, Aosai F, Mun H-S, Norose K, Ahmed AK, Furuya M Yano A (2006) Anaphylactic reaction induced by Toxoplasma gondii-derived heat shock protein 70. Int Immunol 18 : 1487 1497.
9. Ferrante A (1989) Tumor necrosis factor α potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release. Infect Immun 57 : 2115 2122.
10. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA Bloom BR (1993) An essential role for interferon in resistance to Mycobacterium tuberculosis infection. J Exp Med 178 : 2249 2254.
11. Herring AC, Lee J, McDonald RA, Toews GB Huffnagle GB (2002) Induction of interleukin-12 and gamma interferon requires tumor necrosis factor-α for protective Th1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection. Infect Immun 70 : 2959 2964.
12. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM Aguet M (1993) Immune response in mice that lack the interferon-γ receptor. Science 259 : 1742 1745.
13. Im SY, Choi JH, Ko HM, Han SJ, Chun SB, Lee HK Ha TY (1997) A protective role of platelet-activating factor in murine candidiasis. Infect Immun 65 : 1321 1326.
14. Ito S, Pedras-Vasconcelos J Klinman DM (2005) CpG oligodeoxynucleotides increase the susceptibility of normal mice to infection by Candida albicans. Infect Immun 73 : 6154 6156.
15. + T cells. J Exp Med 176 : 581 586.
16. Jakob T, Walker PS, Krieg AM, Udey MC Vogel JC (1998) Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J Immunol 161 : 3042 3049.
17. Jozsef L, Khreiss T Filep JG (2004) CpG motifs in bacterial DNA delay apoptosis of neutrophil granulocytes. FASEB J 18 : 1776 1778.
18. Klinman DM, Yi AK, Beaucage SL, Conover J Krieg AM (1996) CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon. Proc Natl Acad Sci USA 93 : 2879 2883.
19. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA Klinman DM (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 : 546 549.
20. Krieg AM, Love-Homan L, Yi AK Harty JT (1998) CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J Immunol 161 : 2428 2434.
21. Kullberg BJ (1997) Trends in immunotherapy of fungal infections. Eur J Clin Microbiol Infect Dis 16 : 51 55.
22. Kwon HJ, Lee KW, Yu SH, Han JH Kim DS (2003) NF-kappaB-dependent regulation of tumor necrosis factor-alpha gene expression by CpG-oligodeoxynucleotides. Biochem Biophys Res Commun 311 : 129 138.
23. Leijh PC, van den Barselaar MT van Furth R (1997) Kinetics of phagocytosis and intracellular killing of Candida albicans by human granulocytes and monocytes. Infect Immun 17 : 313 318.
24. Liu T, Matsuguchi T, Tsuboi N, Yajima T Yoshikai Y (2002) Differences in expression of toll-like receptors and their reactivities in dendritic cells in BALB/c and C57BL/6 mice. Infect Immun 70 : 6638 6645.
25. Louie A, Baltch AL, Smith RP, Feanke MA, Ritz WJ, Singh JK Gordon MA (1994) Tumor necrosis factor-α has a protective role in a murine model of systemic candidiasis. Infect Immun 62 : 2761 2772.
26. Luyer MD, Buurman WA, Hadfoune M, Wolfs T, Van't Veer C, Jacobs JA, Dejong CH Greve JW (2007) Exposure to bacterial DNA before hemorrhagic shock strongly aggravates systemic inflammation and gut barrier loss via an IFN-γ-dependent route. Ann Surg 245 : 795 802.
27. + T cells. Clin Exp Immunol 140 : 220 229.
28. Montagnoli C, Sandini S, Bacci A, Romani L La Valle R (2004) Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis. Med Mycol 42 : 319 324.
29. Netea MG, van Tits LJ, Curfs JH, Amiot F, Meis JF, van der Meer JW Kullberg BJ (1999) Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. J Immunol 163 : 1498 505.
30. Portnoy DA (1992) Innate immunity to a facultative intracellular bacterial pathogen. Curr Opin Immunol 4 : 20 24.
31. + subset expression in murine candidiasis: Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. J Immunol 150 : 925 931.
32. Romani L, Mencacci A, Tonnetti L, Spaccapelo R, Cenci E, Puccetti P, Wolf SF Bistoni F (1994) IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J Immunol 153 : 5167 5175.
33. Romani L, Bistoni F, Mencacci A, Cenci E, Spaccapelo R Puccetti P (1996a) IL-12 in Candida albicans infections. Res Immunol 146 : 532 538.
34. + T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J Exp Med 183 : 1345 1355.
35. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althage A, Zinkernagel R, Steinmetz M Bluethmann H (1993) Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364 : 798 802.
36. Schwartz DA, Quinn TJ, Thorne PS, Sayeed S, Yi AK Krieg AM (1997) CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. J Clin Invest 100 : 68 73.
37. Spaccapelo R, Romani L, Tonnetti L, Cenci E, Mencacci A, Del Sero G, Tognellini R, Reed SG, Puccetti P Bistoni F (1995) TGF-beta is important in determining the in vivo patterns of susceptibility or resistance in mice infected with Candida albicans. J Immunol 155 : 1349 1360.
38. Spellberg BJ, Filler SG Edwards JE Jr. (2006) Current treatment strategies for disseminated candidiasis. Clin Infect Dis 42 : 244 251.
39. Sun S, Kishimoto H Sprent J (1998) DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell response to specific antigen. J Exp Med 187 : 1145 1150.
40. Tripp CS, Wolf SF Unanue ER (1993) Interleukin 12 and tumor necrosis factor-α are costimulators of interferon-γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 90 : 3725 3729.
41. van't Wout JW, Linde I, Leijh PC van Furth R (1988) Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida albicans infection. Eur J Clin Microbiol Infect Dis 7 : 736 741.
42. Walker PS, Scharton-Kersten T, Krieg AM, Love-Homan L, Rowton ED, Udey MC Vogel JC (1999) Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-γ-dependent mechanisms. Proc Natl Acad Sci USA 96 : 6970 6975.
43. Weighardt H, Feterowski C, Veit M, Rump M, Wagner H Holzmann B (2000) Increased resistance against acute polymicrobial sepsis in mice challenged with immunostimulatory CpG oligonucleotides is related to an enhanced innate effector cell response. J Immunol 1654 : 537 4543.
44. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39 : 309 317.